Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.

scientific article published on 21 April 2010

Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1210/JC.2010-0119
P698PubMed publication ID20410219
P5875ResearchGate publication ID43247393

P50authorJens Juul HolstQ28373106
Jonatan Ising BaggerQ58110286
Katrine B HansenQ59542885
Filip K KnopQ59659637
P2093author name stringT Vilsbøll
P433issue7
P407language of work or nameEnglishQ1860
P921main subjectinsulin resistanceQ1053470
P304page(s)3309-3317
P577publication date2010-04-21
P1433published inThe Journal of Clinical Endocrinology and MetabolismQ3186902
P1476titleReduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects
P478volume95

Reverse relations

cites work (P2860)
Q38015162Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications
Q35769505Calorie Restriction and Matched Weight Loss From Exercise: Independent and Additive Effects on Glucoregulation and the Incretin System in Overweight Women and Men
Q35744498Defects in GLP-1 response to an oral challenge do not play a significant role in the pathogenesis of prediabetes
Q39212408Diabetes in Cushing Disease
Q40147836Diabetic and nondiabetic patients with nonalcoholic fatty liver disease have an impaired incretin effect and fasting hyperglucagonaemia.
Q94545107Dulaglutide improves glucocorticoid-induced hyperglycemia in inpatient care and reduces dose and injection frequency of insulin
Q38007405Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development
Q51328766Endogenous amylin and glucagon-like peptide-1 concentrations are not associated with gastric emptying in critical illness.
Q34721183Exenatide improves glucocorticoid-induced glucose intolerance in mice
Q51346211Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
Q42576497Glucagon-like peptide-1 receptor agonist treatment prevents glucocorticoid-induced glucose intolerance and islet-cell dysfunction in humans.
Q36506631Glucocorticoids and type 2 diabetes: from physiology to pathology
Q33754087Impact of early versus late enteral nutrition on cell mediated immunity and its relationship with glucagon like peptide-1 in intensive care unit patients: a prospective study
Q51363927Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Q48308334Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?
Q38038655Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia
Q41082128Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis
Q48245873Insulin resistance and bone: a biological partnership
Q36783856Loss of incretin effect is a specific, important, and early characteristic of type 2 diabetes
Q36736473Nine months of combined training improves ex vivo skeletal muscle metabolism in individuals with type 2 diabetes
Q38122004Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
Q35760279Physiology of incretins in health and disease
Q91121478Physiology of the Incretin Hormones, GIP and GLP-1-Regulation of Release and Posttranslational Modifications
Q35849382SUMO downregulates GLP-1-stimulated cAMP generation and insulin secretion
Q47834909Systematic-analysis of mRNA expression profiles in skeletal muscle of patients with type II diabetes: The glucocorticoid was central in pathogenesis
Q38247488Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.
Q48278731The effect of 8 days of strict bed rest on the incretin effect in healthy volunteers
Q38245233The role of glucagon on type 2 diabetes at a glance.
Q35680897β-Cell Sensitivity to GLP-1 in Healthy Humans Is Variable and Proportional to Insulin Sensitivity

Search more.